NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Scientific Officer Laura Sepp-Lorenzino sold $66K of Intellia Therapeutics, Inc.
Sold$65,682
$28.87Price
2,275Shares
−5%Stake
What NTLA did after the filing
- The stock from Wed, Jan 10 close, $28.88
- −9.6%
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Feb 23 close.
Traded Mon, Jan 8. Filed Wed, Jan 10, 11:15 AM ET, during the session. Returns use the Jan 10 close and the Feb 23 close. Not investment advice.